Entrada Therapeutics, Inc. · NASDAQ:TRDA

Entrada Therapeutics, Inc. shareholders

As of Sep 30, 2026, 128 institutions reported holding Entrada Therapeutics, Inc., 79.0% of its shares. Largest: Baker Bros. Advisors LP, 5AM Venture Management, LLC and BlackRock. New holders, exits, insiders and big stakes, each with its filing.

HolderShares% of Entrada Therapeutics, Inc.ChangeFiled
Baker Bros. Advisors LP5.07M13.0%no changeNov 16, 2026
5AM Venture Management, LLC3.78M9.7%−272KNov 16, 2026
BlackRock3.24M8.3%+654KNov 13, 2026
Merck & Co., Inc.1.74M4.4%no changeNov 13, 2026
Vanguard1.72M4.4%+19,710Nov 13, 2026
Trails Edge Capital Partners, LP1.43M3.6%newNov 16, 2026
TCG Crossover Management, LLC1.06M2.7%no changeNov 16, 2026
Wellington954K2.4%no changeNov 16, 2026
StepStone Group LP761K1.9%no changeNov 17, 2026
Geode Capital708K1.8%−8,940Nov 6, 2026

Entrada Therapeutics, Inc. insider trades